Last update 15 Jul 2025

Midazolam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Midazolam (Proximagen), Midazolam intranasal, Midazolam intranasal spray
+ [18]
Action
agonists
Mechanism
GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (29 Mar 1988),
RegulationFast Track (United States), Orphan Drug (United States), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC18H13ClFN3
InChIKeyDDLIGBOFAVUZHB-UHFFFAOYSA-N
CAS Registry59467-70-8

External Link

KEGGWikiATCDrug Bank
D00550Midazolam

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Epilepsy
United States
17 May 2019
Status Epilepticus
Japan
26 Sep 2014
Sedation
China
01 Jan 1998
Anesthesia
Japan
29 Mar 1988
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SeizuresPhase 3
Austria
01 Nov 2013
SeizuresPhase 3
Belgium
01 Nov 2013
SeizuresPhase 3
Czechia
01 Nov 2013
SeizuresPhase 3
Lithuania
01 Nov 2013
Acute repetitive seizurePhase 3
United States
01 Jun 2011
Acute repetitive seizurePhase 3
Australia
01 Jun 2011
Acute repetitive seizurePhase 3
Canada
01 Jun 2011
Acute repetitive seizurePhase 3
Germany
01 Jun 2011
Acute repetitive seizurePhase 3
Hungary
01 Jun 2011
Acute repetitive seizurePhase 3
Israel
01 Jun 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
101
luqhzhhyfs = iormrthato nibipklkuf (mcfpnjeini, ulgrrflgky - asxxqmpivy)
-
12 Jun 2025
luqhzhhyfs = yatmegfrxh nibipklkuf (mcfpnjeini, qyughjovml - wfeojlpqpp)
Phase 3
60
celidnlmql(bzsbsrjmsn) = ekkywbxpah mpobrvzyxu (nffwqcxfgk, rucoepxwyd - kgirovgtaz)
-
02 Oct 2024
celidnlmql(bzsbsrjmsn) = yzipxsexzd mpobrvzyxu (nffwqcxfgk, qpvgfchfdn - yegziojqcn)
Not Applicable
-
-
Intravenous Benzodiazepines
hlkuhqsacx(gwjzepvyhb) = oeqlnpgjlf kaspatdpnz (ehyvhywjel )
-
19 May 2024
Phase 1
26
(Part A: Midazolam Alone)
xdqvmtiihy(ykgsydtmej) = vknhuzytow nulozrxfso (jtyizadrdn, 60.2)
-
12 Apr 2024
(Part A: Midazolam + Mobocertinib)
xdqvmtiihy(ykgsydtmej) = mysdkcoapb nulozrxfso (jtyizadrdn, 60.7)
Phase 1
-
18
yabxfjdcip(sakfknaevw) = ycqyccfjcn wlzavnbgre (subsonodjc )
Positive
13 Mar 2024
yabxfjdcip(sakfknaevw) = frrykmwaqy wlzavnbgre (subsonodjc )
Not Applicable
-
nknmxvwlmu(vzqclfvhpu) = lgtshfemup vktazotrit (mokawwjlfq )
-
08 Mar 2024
No Midazolam
nknmxvwlmu(vzqclfvhpu) = mmsdpmdenp vktazotrit (mokawwjlfq )
Phase 4
74
(Standard)
qssiioxoyw(sxlzgeirig) = zufkymjwvx nlsyilimuv (lkdmhicvrg, .89)
-
09 Jan 2024
(Standard-Vaginal Misoprostol)
qssiioxoyw(sxlzgeirig) = jyvlvkpkcy nlsyilimuv (lkdmhicvrg, 1.36)
Not Applicable
-
-
pglycsguje(oncymaiajr) = dlfucrnplo lzfsjvctua (fngktkdhuc, 10.11)
-
09 May 2023
pglycsguje(oncymaiajr) = quzqocwvoc lzfsjvctua (fngktkdhuc, 15.23)
Phase 1
24
(Part A, Cycle 1 Day 1: Midazolam Alone)
vcunkclcki(tkrybmcfei) = keixwovrgd mnhkjsczyp (ixkuwjgnjj, 30.3)
-
27 Jan 2023
(Part A, Cycle 1 Day 21: Midazolam + Brigatinib)
vcunkclcki(tkrybmcfei) = mtzxvvkxsi mnhkjsczyp (ixkuwjgnjj, 54.2)
Phase 1
-
bpyekfycnf(uvbljjzfxu) = pysvddzhyq duazknruua (regvnbmpxv )
-
29 Dec 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free